Global OTC Anti-Infective Medications Market Growth (Status and Outlook) 2021-2026

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Years Considered
• 1.3 Research Objectives
• 1.4 Market Research Methodology
• 1.5 Research Process and Data Source
• 1.6 Economic Indicators
• 1.7 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global OTC Anti-Infective Medications Market Size 2016-2026
  • 2.1.2 OTC Anti-Infective Medications Market Size CAGR by Region 2020 VS 2021 VS 2026
• 2.2 OTC Anti-Infective Medications Segment by Type
  • 2.2.1 Antifungals
  • 2.2.2 Antifungals
  • 2.2.3 Antiparasitics
• 2.3 OTC Anti-Infective Medications Market Size by Type
  • 2.3.1 Global OTC Anti-Infective Medications Market Size CAGR by Type
  • 2.3.2 Global OTC Anti-Infective Medications Market Size Market Share by Type (2016-2021)
• 2.4 OTC Anti-Infective Medications Segment by Sales Channel
  • 2.4.1 Hospital Pharmacies
  • 2.4.2 Drug Stores
  • 2.4.3 E-Commerce
• 2.5 OTC Anti-Infective Medications Market Size by Sales Channel
  • 2.5.1 Global OTC Anti-Infective Medications Market Size CAGR by Sales Channel
  • 2.5.2 Global OTC Anti-Infective Medications Market Size Market Share by Sales Channel (2016-2021)

3 OTC Anti-Infective Medications Market Size by Players

• 3.1 OTC Anti-Infective Medications Market Size Market Share by Players
  • 3.1.1 Global OTC Anti-Infective Medications Revenue by Players (2019-2021E)
  • 3.1.2 Global OTC Anti-Infective Medications Revenue Market Share by Players (2019-2021E)
• 3.2 Global OTC Anti-Infective Medications Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 OTC Anti-Infective Medications by Regions

• 4.1 OTC Anti-Infective Medications Market Size by Regions (2016-2021)
• 4.2 Americas OTC Anti-Infective Medications Market Size Growth (2016-2021)
• 4.3 APAC OTC Anti-Infective Medications Market Size Growth (2016-2021)
• 4.4 Europe OTC Anti-Infective Medications Market Size Growth (2016-2021)
• 4.5 Middle East & Africa OTC Anti-Infective Medications Market Size Growth (2016-2021)

5 Americas

• 5.1 Americas OTC Anti-Infective Medications Market Size by Country (2016-2021)
• 5.2 Americas OTC Anti-Infective Medications Market Size by Type (2016-2021)
• 5.3 Americas OTC Anti-Infective Medications Market Size by Sales Channel (2016-2021)
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Brazil

6 APAC

• 6.1 APAC OTC Anti-Infective Medications Market Size by Region (2016-2021)
• 6.2 APAC OTC Anti-Infective Medications Market Size by Type (2016-2021)
• 6.3 APAC OTC Anti-Infective Medications Market Size by Sales Channel (2016-2021)
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia

7 Europe

• 7.1 Europe OTC Anti-Infective Medications by Country (2016-2021)
• 7.2 Europe OTC Anti-Infective Medications Market Size by Type (2016-2021)
• 7.3 Europe OTC Anti-Infective Medications Market Size by Sales Channel (2016-2021)
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia

8 Middle East & Africa

• 8.1 Middle East & Africa OTC Anti-Infective Medications by Region (2016-2021)
• 8.2 Middle East & Africa OTC Anti-Infective Medications Market Size by Type (2016-2021)
• 8.3 Middle East & Africa OTC Anti-Infective Medications Market Size by Sales Channel (2016-2021)
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global OTC Anti-Infective Medications Market Forecast

• 10.1 Global OTC Anti-Infective Medications Forecast by Regions (2021-2026)
  • 10.1.1 Global OTC Anti-Infective Medications Forecast by Regions (2021-2026)
  • 10.1.2 Americas OTC Anti-Infective Medications Forecast
  • 10.1.3 APAC OTC Anti-Infective Medications Forecast
  • 10.1.4 Europe OTC Anti-Infective Medications Forecast
  • 10.1.5 Middle East & Africa OTC Anti-Infective Medications Forecast
• 10.2 Americas OTC Anti-Infective Medications Forecast by Countries (2021-2026)
  • 10.2.1 United States OTC Anti-Infective Medications Market Forecast
  • 10.2.2 Canada OTC Anti-Infective Medications Market Forecast
  • 10.2.3 Mexico OTC Anti-Infective Medications Market Forecast
  • 10.2.4 Brazil OTC Anti-Infective Medications Market Forecast
• 10.3 APAC OTC Anti-Infective Medications Forecast by Region (2021-2026)
  • 10.3.1 China OTC Anti-Infective Medications Market Forecast
  • 10.3.2 Japan OTC Anti-Infective Medications Market Forecast
  • 10.3.3 Korea OTC Anti-Infective Medications Market Forecast
  • 10.3.4 Southeast Asia OTC Anti-Infective Medications Market Forecast
  • 10.3.5 India OTC Anti-Infective Medications Market Forecast
  • 10.3.6 Australia OTC Anti-Infective Medications Market Forecast
• 10.4 Europe OTC Anti-Infective Medications Forecast by Country (2021-2026)
  • 10.4.1 Germany OTC Anti-Infective Medications Market Forecast
  • 10.4.2 France OTC Anti-Infective Medications Market Forecast
  • 10.4.3 UK OTC Anti-Infective Medications Market Forecast
  • 10.4.4 Italy OTC Anti-Infective Medications Market Forecast
  • 10.4.5 Russia OTC Anti-Infective Medications Market Forecast
• 10.5 Middle East & Africa OTC Anti-Infective Medications Forecast by Region (2021-2026)
  • 10.5.1 Egypt OTC Anti-Infective Medications Market Forecast
  • 10.5.2 South Africa OTC Anti-Infective Medications Market Forecast
  • 10.5.3 Israel OTC Anti-Infective Medications Market Forecast
  • 10.5.4 Turkey OTC Anti-Infective Medications Market Forecast
  • 10.5.5 GCC Countries OTC Anti-Infective Medications Market Forecast
• 10.6 Global OTC Anti-Infective Medications Forecast by Type (2021-2026)
• 10.7 Global OTC Anti-Infective Medications Forecast by Sales Channel (2021-2026)

11 Key Players Analysis

• 11.1 GlaxoSmithKline
  • 11.1.1 GlaxoSmithKline Company Information
  • 11.1.2 GlaxoSmithKline OTC Anti-Infective Medications Product Offered
  • 11.1.3 GlaxoSmithKline OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
  • 11.1.4 GlaxoSmithKline Main Business Overview
  • 11.1.5 GlaxoSmithKline Latest Developments
• 11.2 Merck
  • 11.2.1 Merck Company Information
  • 11.2.2 Merck OTC Anti-Infective Medications Product Offered
  • 11.2.3 Merck OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
  • 11.2.4 Merck Main Business Overview
  • 11.2.5 Merck Latest Developments
• 11.3 Pfizer
  • 11.3.1 Pfizer Company Information
  • 11.3.2 Pfizer OTC Anti-Infective Medications Product Offered
  • 11.3.3 Pfizer OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
  • 11.3.4 Pfizer Main Business Overview
  • 11.3.5 Pfizer Latest Developments
• 11.4 Novartis
  • 11.4.1 Novartis Company Information
  • 11.4.2 Novartis OTC Anti-Infective Medications Product Offered
  • 11.4.3 Novartis OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
  • 11.4.4 Novartis Main Business Overview
  • 11.4.5 Novartis Latest Developments
• 11.5 Abbott
  • 11.5.1 Abbott Company Information
  • 11.5.2 Abbott OTC Anti-Infective Medications Product Offered
  • 11.5.3 Abbott OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
  • 11.5.4 Abbott Main Business Overview
  • 11.5.5 Abbott Latest Developments
• 11.6 Sanofi
  • 11.6.1 Sanofi Company Information
  • 11.6.2 Sanofi OTC Anti-Infective Medications Product Offered
  • 11.6.3 Sanofi OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
  • 11.6.4 Sanofi Main Business Overview
  • 11.6.5 Sanofi Latest Developments
• 11.7 Bristol-Myers Squibb
  • 11.7.1 Bristol-Myers Squibb Company Information
  • 11.7.2 Bristol-Myers Squibb OTC Anti-Infective Medications Product Offered
  • 11.7.3 Bristol-Myers Squibb OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
  • 11.7.4 Bristol-Myers Squibb Main Business Overview
  • 11.7.5 Bristol-Myers Squibb Latest Developments
• 11.8 Roche
  • 11.8.1 Roche Company Information
  • 11.8.2 Roche OTC Anti-Infective Medications Product Offered
  • 11.8.3 Roche OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
  • 11.8.4 Roche Main Business Overview
  • 11.8.5 Roche Latest Developments
• 11.9 NanoViricides
  • 11.9.1 NanoViricides Company Information
  • 11.9.2 NanoViricides OTC Anti-Infective Medications Product Offered
  • 11.9.3 NanoViricides OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
  • 11.9.4 NanoViricides Main Business Overview
  • 11.9.5 NanoViricides Latest Developments
• 11.10 Novabay Pharmaceuticals
  • 11.10.1 Novabay Pharmaceuticals Company Information
  • 11.10.2 Novabay Pharmaceuticals OTC Anti-Infective Medications Product Offered
  • 11.10.3 Novabay Pharmaceuticals OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
  • 11.10.4 Novabay Pharmaceuticals Main Business Overview
  • 11.10.5 Novabay Pharmaceuticals Latest Developments

11. Optimer Pharmaceuticals

• 11.11.1 Optimer Pharmaceuticals Company Information
• 11.11.2 Optimer Pharmaceuticals OTC Anti-Infective Medications Product Offered
• 11.11.3 Optimer Pharmaceuticals OTC Anti-Infective Medications Revenue, Gross Margin and Market Share (2019-2021)
• 11.11.4 Optimer Pharmaceuticals Main Business Overview
• 11.11.5 Optimer Pharmaceuticals Latest Developments

12 Research Findings and Conclusion